This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n8http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n12http://linked.opendata.cz/resource/drugbank/drug/DB03869/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/drugbank/drug/DB03869/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03869/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB03869/identifier/drugbank/

Statements

Subject Item
n2:DB03869
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB03869 n8:DB03869
dcterms:title
5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine
adms:identifier
n10:DB03869 n11:46508279 n12:SSA n13:46936812
n3:IUPAC-Name
n4:271B4A85-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4A8B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4A8A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4A87-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4A88-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4A89-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4A83-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4A81-363D-11E5-9242-09173F13E4C5 n4:271B4A84-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4A82-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4A91-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4A92-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4A8C-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4A8D-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4A8F-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4A8E-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4A90-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4A97-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4A99-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4A9A-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4A96-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4A95-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4A98-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4A86-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4A93-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4A94-363D-11E5-9242-09173F13E4C5